Oxford BioDynamics PLC has received a notification of major holdings from Dr. Alexandre Akoulitchev, indicating an event changing the breakdown of voting rights. The notification, dated April 5, 2024, reveals that Dr. Akoulitchev now holds 2.994% of voting rights attached to shares, representing a total of 6,603,082 voting rights in the company.

The notification specifies that there are no indirect voting rights held by Dr. Akoulitchev and no voting rights through financial instruments. It also confirms that Dr. Akoulitchev is not controlled by any natural person or legal entity and does not control any other undertaking holding an interest in the issuer.

This notification provides an insight into the changes in voting rights within Oxford BioDynamics PLC and the details of the shareholder involved. It offers transparency regarding the ownership and control of voting rights within the company, as required by regulatory standards.